US Patent 8273365 Two-piece, internal-channel osmotic delivery system flow modulator

Patent 8273365 was granted and assigned to Intarcia Therapeutics on September, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Intarcia Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

82733650

Patent Inventor Names

Pedro E. de la Serna0

Michael A. DesJardin0

Pauline C. Zamora0

Scott D. Lautenbach0

Date of Patent

September 25, 2012

Patent Application Number

134332870

Date Filed

March 29, 2012

Patent Citations Received

‌

US Patent 11654183 Methods comprising continuous administration of exenatide and co-administration of a drug

‌

US Patent 11840559 Glucagon-receptor selective polypeptides and methods of use thereof

Patent Primary Examiner

‌

Blessing Fubara

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8273365 Two-piece, internal-channel osmotic delivery system flow modulator

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API